Vitiligo: How do oxidative stress-induced autoantigens trigger autoimmunity?

Area of Science:

• Dermatology
• Immunology
• Oxidative Stress Research

Background:

• Vitiligo is a depigmentation disorder involving melanocyte loss.
• Oxidative stress and autoimmunity are hypothesized key factors in vitiligo pathogenesis.
• Reactive oxygen species (ROS) accumulation contributes to melanocyte damage.

Purpose of the Study:

• To elucidate the role of oxidative stress and autoimmunity in vitiligo.
• To explore mechanisms of melanocyte damage and autoantigen production.
• To review potential therapeutic strategies targeting ROS and immune responses.

Main Methods:

• Review of literature on vitiligo pathogenesis.
• Analysis of factors contributing to ROS overproduction in melanocytes.
• Examination of autoantigen presentation and immune cell activation pathways.

Main Results:

• Multiple factors contribute to ROS accumulation, including genetic and environmental stimuli, and reduced antioxidant capacity.
• ROS leads to melanocyte apoptosis, endoplasmic reticulum stress, and autoantigen release.
• Immune responses, including cellular immunity and dendritic cell maturation, target melanocytes.

Conclusions:

• Oxidative stress-induced melanocyte damage and subsequent autoimmunity are central to vitiligo.
• Therapies reducing ROS (e.g., narrow band ultraviolet, quercetin) and modulating autoimmunity (e.g., regulatory T cells) are promising for repigmentation.